In this 20 minute podcast, Dr Emma Nash speaks to Dr Sally Higginbottom about adverse effects of antipsychotic medication, with a focus on movement disorders and strategies to detect them early in routine practice.
Funding for this podcast was received from Teva Pharmaceuticals. Teva Pharmaceuticals reviewed the content for scientific accuracy and full editorial control remains the sole responsibility of the RCGP.
Cardiovascular disease (CVD) is the leading global cause of death, with an estimated 18 million deaths each year (over 30% of all global deaths). In 2022, around 175,000 people in the UK died from CVD, accounting for about 27% of all deaths — the second most common cause of death after dementia and Alzheimer's disease.
In this podcast, Dr Thomas Round talks to Dr Nicholas Jones, a salaried GP in Oxford with a special interest in cardiology, about primary risk assessment and lipid management in cardiovascular disease.
EKU Programme module on Cardiovascular disease: risk assessment, reduction & lipid modification.
British Journal of General Practice article on Cardiovascular disease — risk assessment and reduction: NICE 2023 update for GPs.
--------
30:41
EKU Podcast: Physical health in severe mental illness
People living with severe mental illness face one of the greatest health equality gaps in England. Their life expectancy is 15–20 years shorter than that for the general population, and this disparity is largely due to preventable physical illnesses.
In this podcast, Dr Thomas Round discusses physical health in people with severe mental illness with Professor Carolyn Chew-Graham, a Professor of General Practice Research at Keele University and a GP in Manchester and Dr David Shiers, Honorary Research Consultant at Psychosis Research Unit and a former GP in North Staffordshire, who became involved in the early intervention reform after his daughter’s experience of a severe psychotic illness.
--------
29:39
Endometriosis
In this podcast Dr. Julie Oliver, chair of the Primary Care Women’s Health Society is interviewed about endometriosis. Starting with the basics of definition and symptoms, the podcast then goes on to discuss more nuanced aspects of care, including decisions about whether to refer or manage empirically, and how to support a patient in primary care while she is on a potentially long list for consultant review. The podcast takes a life course approach, ending with a discussion about management of the menopause in women who have had endometriosis, and the need to remember that symptoms may persist even after apparently definitive surgical treatment.
An educational grant was received from Scottish Government for the production of this podcast. Editorial and content decisions were made solely by the RCGP.
--------
15:38
EKU Podcast: The evolving role of GLP1-RA in obesity
Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are a class of drugs initially developed to treat type 2 diabetes and are now becoming more widely used for obesity. They work by mimicking the actions of the GLP-1 hormone, which is released by the gut after eating. GPs will be used to prescribing them for type 2 diabetes, but less so for obesity.
In this podcast, Dr Thomas Round discusses the evolving role of GLP1-RA in obesity, the benefits and potential side effects, the role of the GP, and the latest NICE guidance in this area with Dr Stephanie DiGiorgio, an urgent care GP with a specialist interest in obesity.
The Royal College of General Practitioners is the professional membership body for family doctors in the UK and overseas. This podcast is produced by the RCGP eLearning and Essential Knowledge Update teams and features discussions with clinical experts about a range of key topics in primary care.
UK